SOST and Osteopenia: Sclerostin levels weresignificantly decreased in osteoporosis (4.62 ± 1.6 ng/mL) and osteopenia (4.92 ± 1.4 ng/mL) compared with controls(5.74 ± 1.3 ng/mL), (p < 0.0001).